Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Src SH3 domain: an antithrombotic target without compromising homeostasis

July 31, 2020

Novel mouse model of AAA with intraluminal thrombus

July 30, 2020

INSERM presents preclinical data for single-domain antibody PS-003

July 28, 2020

FRSW-107 demonstrates extended half-life in patients with hemophilia A

July 28, 2020

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

July 27, 2020

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

July 27, 2020

MPI-8 reduces thrombosis without increased bleeding in vivo

July 27, 2020

In vivo studies show potent reversal of anticoagulation with VMX-COO1

July 24, 2020

Researchers develop mouse model for imaging of Ca2+ changes in platelets

July 22, 2020

Phase III data presented for SCT-800 in severe hemophilia A patients

July 22, 2020

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...